PD‐L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis
- 20 June 2016
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 43 (8), 663-670
- https://doi.org/10.1111/cup.12728
Abstract
Programmed cell death ligand 1 (PD-L1) expression in primary cutaneous squamous cell carcinoma has not been described.We reviewed immunohistochemical stained sections of forty primary and five metastatic cutaneous squamous cell carcinomas using antibody to PD-L1 and classified the staining pattern according to the DAKO tumor proportion score method. We compared the staining results with microscopic staging parameters associated with risk of metastasis including tumor diameter, histologic grade, tumor thickness and perineural invasion.PD-L1 expression was present in 4 of 20 low risk tumors (20%), all of which showed low expression. PD-L1 expression was present in 14 of 20 high risk tumors (70%), 12 of which showed low expression and 2 of which showed high expression. 5 of 5 metastases (100%), with 3 showing low expression and 2 showing high expression.This survey documents PD-L1 expression in cutaneous squamous cell carcinoma and shows a positive correlation between the degree PD-L1 expression and pathologic findings related to risk of metastasis including large diameter, higher histological grade and tumor thickness.Keywords
This publication has 18 references indexed in Scilit:
- Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific DeathJAMA Dermatology, 2016
- A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 InhibitorJAMA Dermatology, 2016
- Outcomes of Patients With Multiple Cutaneous Squamous Cell CarcinomasJAMA Dermatology, 2015
- Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration statusLaboratory Investigation, 2015
- Combination cancer immunotherapy and new immunomodulatory targetsNature Reviews Drug Discovery, 2015
- Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineEuropean Journal of Cancer, 2015
- Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 ExpressionCancer Cell, 2014
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinomaLaboratory Investigation, 2010